The impact of exposure model misspecification on signal detection in prospective pharmacovigilance-Reference-Cited by-同舟云学术

The impact of exposure model misspecification on signal detection in prospective pharmacovigilance

Published:2014-09-04 Issue:5 Volume:24 Page:456-467
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

van Gaalen Rolina D.¹,Abrahamowicz Michal¹²,Buckeridge David L.¹

Affiliation:

1. Department of Epidemiology, Biostatistics, and Occupational Health; McGill University; Montréal Québec Canada

2. Division of Clinical Epidemiology; McGill University Health Centre; Montréal Québec Canada

Funder

Canadian Institutes for Health Research (CIHR)

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference63 articles.

1. External validity of randomised controlled trials: “to whom do the results of this trial apply?”;Rothwell;Lancet,2005

2. Why we need observational studies to evaluate the effectiveness of health care;Black;Br Med J,1996

3. WHO Medicines - Pharmacovigilance 2012 http://www.who.int/medicines/areas/qualitysafety/safetyefficacy/pharmvigi/en/

4. FDA Guidance drug safety information - FDA's communication to the public 2007 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm

5. A critical review of methods to evaluate the impact of FDA regulatory actions;Briesacher;Pharmacoepidemiol Drug Saf,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling of cumulative effects of time-varying drug exposures on within-subject changes in a continuous outcome;Statistical Methods in Medical Research;2020-02-05

2. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis;Diabetes & Metabolism;2017-10

3. Competing risks modeling of cumulative effects of time-varying drug exposures;Statistical Methods in Medical Research;2017-09-07

4. Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance;Drug Safety;2017-06-29

5. Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution;Pharmacoepidemiology and Drug Safety;2017-05-03